Patients ’ preferences of cutaneous leishmaniasis treatment outcomes: Findings from an international qualitative study
Conclusions/SignificanceThe study results provide a rich insight into important outcomes for CL treatments, as well as related topics, from the perspective of a diverse patient population. Among the outcomes identified, we argue that those related to quality of life as well as recurrence should be included to a greater extent for assessment in clinical trials, and discuss the suitability of measurement instruments such as the Dermatology Quality of Life Index (DLQI). Interviews also point out the potential need to address concerns related to parasitological cure or scar formation, such as social stigmatization and disability. In addition, patients should be given information in order to clarify reported misconceptions. This study therefore suggests a methodology for consulting CL patients on outcomes as elements of clinical trial design, and how to incorporate these outcomes in trials. It also discusses how reported outcomes could be addressed in clinical care.
Source: PLoS Neglected Tropical Diseases - Category: Tropical Medicine Authors: Astrid C. Erber Source Type: research
More News: Brazil Health | Burkina Faso Health | Clinical Trials | Colombia Health | Dermatology | Disability | Endemics | Iran Health | Middle East Health | Morocco Health | Pain | Parasitic Diseases | Parasitology | Peru Health | Skin | Study | Tropical Medicine | Tunisia Health